Stephen Krieger, MD FAAN
Associate Professor of Neurology
Corinne Goldsmith Dickinson Center for MS
Director, Neurology Residency Program
Icahn School of Medicine at Mount Sinai
New York, NY
Andrew J. Solomon, MD
Assistant Professor of Neurological Sciences
Division Chief, Multiple Sclerosis
University of Vermont College of Medicine
Method of Participation
Participants should read the activity information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test, you will be directed to a Web page that will allow you to receive your certificate of credit via e-mail or you may print it out at that time.
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Global Academy of Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
The recent approval and availability of a multitude of new options for MS management has led clinicians to reconsider their approach to the diagnosis of the disease, as well as the timing, approach, and aggressiveness of initial treatment. MS symptoms may often be subclinical or incorrectly attributed to another cause, potentially delaying treatment until the disease has already begun to progress. Earlier and more accurate diagnosis to guide treatment offers opportunities to improve patient outcomes and quality of life.
At the conclusion of this program, participants should be better able to:
- Discuss the role of radiologically isolated syndromes (RIS) and clinically isolated syndromes (CIS) in diagnosing and monitoring MS.
- Describe recent updates to established MS disease phenotypes and discuss their application in clinical practice.
- Recognize the importance of early diagnosis and treatment in reducing disability progression.
- Identify important risk factors impacting the onset, severity, and progression of MS.
- Understand and apply recent discoveries and emerging therapies in the management of patients with MS.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Stephen Krieger, MD, FAAN: Consultant: Acorda, Bayer, Biogen, EMD Serono,
Genentech, Genzyme, Mallinckrodt, MedDay, Novartis, Teva, TG Therapeutics. Speakers bureau: Biogen
Andrew J. Solomon, MD: Consultant: Biogen, EMD Serono, Genentech. Grant/Research Support: Biogen
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Global Academy for Medical Education Staff: Sylvia H. Reitman, MBA, DipEd; Mike LoPresti; Shirley V. Jones, MBA; Ron Schaumburg; and Tom Garry hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products
or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Global Education Group (Global): The following planners and managers, Ashley Marostica, RN, MSN; Andrea Funk; Liddy Knight have nothing to disclose.
Off-Label/Investigational Use Disclosure
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The planners of this activity do not recommend the use of any agent outside of the labeled indications.